Breakfast replacement by a low-glycemic index liquid formula in patients with diabetes mellitus type 2

Breakfast replacement by a low-glycemic index liquid formula in patients with diabetes mellitus type 2 - BREAK

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON34073

Enrollment

Registered

2011-01-21

Start date

2010-05-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Isoenergetic replacement of regular whole-food breakfast by Glucerna SR drinkvoeding (Abbott Laboratories B.V., Zwolle, Netherlands) will be compared to regular whole-food breakfast

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: diabetes mellitus type 2

Exclusion criteria

Exclusion criteria: - use of any other anti-diabetic drug than metformin - acute or chronic metabolic disease (other than diabetes) that will impair metabolism or digestion and absorption of food, including gastrointestinal, hepatic or renal disease - regular breakfast skipping - inability to give written informed consent

Design outcomes

Primary

Measure	Time frame
Fasting and postprandial glucose and insulin concentrations	—

Secondary

Measure	Time frame
body weight, HbA1c, glucose tolerance (determined by an oral glucose tolerance test), plasma lipid concentrations, oxidative stress	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)